These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37140510)

  • 1. Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF.
    Michaëlsson E; Lund LH; Hage C; Shah SJ; Voors AA; Saraste A; Redfors B; Grove EL; Barasa A; Richards AM; Svedlund S; Lagerström-Fermér M; Gabrielsen A; Garkaviy P; Gan LM; Lam CSP
    JACC Heart Fail; 2023 Jul; 11(7):775-787. PubMed ID: 37140510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results.
    Lam CSP; Lund LH; Shah SJ; Voors AA; Erlinge D; Saraste A; Pirazzi C; Grove EL; Barasa A; Schou M; Aziz A; Svedlund S; Wijngaarden JV; Lindstedt EL; Gustavsson A; Nelander K; Garkaviy P; Gan LM; Gabrielsen A
    J Card Fail; 2024 Jan; 30(1):104-110. PubMed ID: 37072105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
    Lund LH; Lam CSP; Pizzato PE; Gabrielsen A; Michaëlsson E; Nelander K; Ericsson H; Holden J; Folkvaljon F; Mattsson A; Collén A; Aurell M; Whatling C; Baldus S; Drelich G; Goudev A; Merkely B; Bergh N; Shah SJ
    Eur J Heart Fail; 2023 Sep; 25(9):1696-1707. PubMed ID: 37470101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
    Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
    ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.
    Inghardt T; Antonsson T; Ericsson C; Hovdal D; Johannesson P; Johansson C; Jurva U; Kajanus J; Kull B; Michaëlsson E; Pettersen A; Sjögren T; Sörensen H; Westerlund K; Lindstedt EL
    J Med Chem; 2022 Sep; 65(17):11485-11496. PubMed ID: 36005476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study.
    Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan RS; Fermer ML; Gan LM; Lund LH; Lam CSP; Shah SJ
    Circulation; 2020 Nov; 142(21):2029-2044. PubMed ID: 33034202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction.
    Kresoja KP; Rommel KP; Wachter R; Henger S; Besler C; Klöting N; Schnelle M; Hoffmann A; Büttner P; Ceglarek U; Thiele H; Scholz M; Edelmann F; Blüher M; Lurz P
    Eur J Heart Fail; 2021 Oct; 23(10):1633-1644. PubMed ID: 34231954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
    Nelander K; Lagerstrom-Fermer M; Amilon C; Michaëlsson E; Heijer M; Kjaer M; Russell M; Han D; Lindstedt EL; Whatling C; Gan LM; Ericsson H
    Clin Transl Sci; 2021 May; 14(3):812-819. PubMed ID: 32770730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
    Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
    J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients.
    Hage C; Michaëlsson E; Kull B; Miliotis T; Svedlund S; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    ESC Heart Fail; 2020 Aug; 7(4):1534-1546. PubMed ID: 32424988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers.
    Gan LM; Lagerström-Fermér M; Ericsson H; Nelander K; Lindstedt EL; Michaëlsson E; Kjaer M; Heijer M; Whatling C; Fuhr R
    Br J Clin Pharmacol; 2019 Apr; 85(4):762-770. PubMed ID: 30618054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction.
    Chen H; Tesic M; Nikolic VN; Pavlovic M; Vucic RM; Spasic A; Jovanovic H; Jovanovic I; Town SEL; Padula MP; McClements L
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction.
    Woolley RJ; Ceelen D; Ouwerkerk W; Tromp J; Figarska SM; Anker SD; Dickstein K; Filippatos G; Zannad F; Metra M; Ng L; Samani N; van Veldhuisen DJ; Lang C; Lam CS; Voors AA
    Eur J Heart Fail; 2021 Jun; 23(6):983-991. PubMed ID: 33651430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.